FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Cell Based Assay Market Overview:

According to FutureWise analysis the market for cell based assay in 2023 is US$ 18.9 billion, and is expected to reach US$ 36.62 billion by 2031 at a CAGR of 8.60%.

Depending on the end-user, the market is fragmented into academic and government institutes, contract research organizations (CRO) and pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology companies segment currently holds the largest market share and this trend will continue over the forecast period. However, the CRO segment is predicted to grow with a high CAGR value during the forecast period. This growth can be attributed to the increased outsourcing of drug discovery activities by pharmaceutical firms to CROs.

The drug discovery segment is predicted to boost market growth over the forecast period. This growth is due to the increase in investments on research and development by pharmaceutical companies. Furthermore, the increasing prevalence of diabetes and cardiovascular diseases is spurring market growth. Moreover, a rapid rise in the drugs used for treating chronic diseases across the world has boosted the market growth.

North America currently dominates the market. However, the Asia Pacific region is predicted to grow at a high CAGR value over the forecast period. The growth in this region is largely due to advancements in infrastructure development and massive investments in research and development by governments of emerging economies.

Major players included in the Cell Based Assay Market:

Thermo Fisher Scientific Inc.
Danaher Corporation
Becton, Dickinson and Company,
GE Healthcare
Merck KGaA
Lonza Group Ltd.
Perkinelmer, Inc.
Charles River Laboratories, Inc.
Cell Signaling Technology, Inc.
Promega Corporation, Cisbio
Cell Biolabs, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Cell Based Assay Market Segmentation:

By Product and Services

Consumables
Reagents
Assay Kits
- Reporter Gene Assays
- Second Messenger Assays
- Cell Growth Assays
- Cell Death Assays
- Other Assay Kits
Probes and Labels
Microplates
Cell Lines
- Immortalized Cell Lines
- Primary Cell Lines
- Stem Cell Lines
Instruments
Services

By Application

Drug Discovery
Toxicity Studies
- Pharmacokinetic Studies
- Pharmacodynamic Studies
Basic Research
Other Applications

By End User

Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations

By Region

North America
Europe
Asia Pacific
Rest of the World

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Cell-based Assay Market By Product And Services, By Application, By End User and By Region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and rest of the world
To record evaluate and competitive landscape mapping-product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible Solution Typel and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Cell Based Assay Market Variables, Trends Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Cell Based Assay Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Cell Based Assay Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Cell Based Assay Market, By Product and Services Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Consumables
  2. Reagents
  3. Assay Kits
  3.1. Reporter Gene Assays
  3.2. Second Messenger Assays
  3.3. Cell Growth Assays
  3.4. Cell Death Assays
  3.5. Other Assay Kits
  4. Probes and Labels
  5. Microplates
  6. Cell Lines
  6.1. Immortalized Cell Lines
  6.2. Primary Cell Lines
  6.3. Stem Cell Lines
  7. Instruments
  8. Services
8. Cell Based Assay Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Drug Discovery
  2. Toxicity Studies
  2.1. Pharmacokinetic Studies
  2.2. Pharmacodynamic Studies
  3. Basic Research
  4. Other Applications
9. Cell Based Assay Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Pharmaceutical and Biotechnology Companies
  2. Academic and Government Institutes
  3. Contract Research Organizations
10. North America Cell Based Assay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
11. Latin America Cell Based Assay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
12. Europe Cell Based Assay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
13. Asia Pacific Cell Based Assay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
14. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2023-2031
15. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. Thermo Fisher Scientific Inc.
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Danaher Corporation
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Becton, Dickinson and Company
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. GE Healthcare
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. Merck KGaA
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Lonza Group Ltd
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Perkinelmer, Inc.
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Charles River Laboratories, Inc.
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Cell Signaling Technology, Inc.
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Promega Corporation
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
  11. Cell Biolabs, Inc.
  11.1. Company Overview
  11.2. Product Portfolio
  11.3. SWOT Analysis
  11.4. Financial Overview
  11.5. Strategic Overview
17. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the regulations initiated by healthcare
  administrations
  5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients